← Leaderboards
Wei Zhang
Juvobio Pharmaceuticals, Inc.
$786,608
Attributed
$899,025
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$899,025 · 4
By mechanism
R43$899,025 · 4
Top collaborators
- Zhexing Wen1 shared
Others in their field
Top investigators on “Glutamates”
- Merit E Cudkowicz · Massachusetts General Hospital$40,827,833
- Alan G. Barbour · University Of California Irvine$39,660,285
- Scott W Woods · Yale University$33,212,495
- Paul F Worley · Johns Hopkins University$32,678,609
- Richard L Huganir · Johns Hopkins University$30,324,803
- John M Kane · Long Island Jewish Medical Center$28,729,148
Research focus
GlutamatesPharmacologic SubstanceSchizophreniaMarketingInnovationAffectNeuronsInduced Pluripotent Stem CellAutistic DisorderMutationCell LineProtocols DocumentationRelating To Nervous SystemPublic HealthBaseParkinson DiseaseProsencephalonDisease ModelDisease PhenotypeAlzheimer&AposNerve Stem CellBrainDrug DiscoveryS Disease
Grant awards (4)
High throughput multiplexed assay for profiling gene expressions of schizophrenia iPSC-derived neurons$224,872
R43 · FY2016 · MH · contact PI
Patient iPSC derived neural synaptic screen for drug discovery$224,836
R43 · FY2016 · MH · contact PI
High throughput multiplexed assay for chemicals affecting neuron differentiation$224,835
R43 · FY2016 · ES · contact PI
Temporal Single Cell RNAseq to Identify Genes and Pathways Affected by 15q11.2 Duplication in Autism iPSC-Derived Differentiating Cortical Neurons$224,482
R43 · FY2016 · MH · contact PI